FluMist, a nasal spray flu vaccine made by AstraZeneca, is now available for at-home use through a service called FluMist ...

American Academy of Pediatrics updates immunization guidelines, and recommends COVID-19 vaccines for young children, ...

AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...

Recent developments in weight-loss treatments have impacted the market significantly. Viking Therapeutics' new pill showed ...

AstraZeneca has launched FluMist Home, a nasal spray flu vaccine with at-home delivery service. For those who have a needle ...

This new option, known as FluMist, was released Friday and is the same vaccine formulation that has been available in doctors' offices for decades. Also in the news: covid, measles, and rabies.

The FDA approved AstraZeneca’s no-prescription FluMist vaccine in September 2024. Now with FluMist Home, people can have it ...

Michigan offers FluMist nasal vaccine delivery, aiming to increase flu vaccinations with the convenience of home administration for individuals aged 2 to 49.

A poll published Aug. 1, 2025, by the health policy organization KFF found half of parents are unsure whether federal health ...

The approval of the new nasal spray comes ahead of this year's influenza season in hopes to prevent the unusually high ...

If you are in one of 34 states, you can now order AstraZeneca's FluMist Home vaccine online to be delivered to your home ...

AstraZeneca's FluMist, FDA-approved for at-home use, said Friday it is offering prescription home delivery in 34 states, ...